JPRN-UMIN000043639已完成未知
Study on therapeutic effect and safety for combination of immune checkpoint inhibitor and molecular-targeted therapies for unresectable hepatocellular carcinoma - Study on Biomarkers in treatment with anti-cancer agents for hepatocellular carcinoma
agoya University Hospital0 个研究点目标入组 91 人开始时间: 2021年3月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 91
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who wish to be excluded from the study. Patients who are pregnant, lactating, may become pregnant, or intend to become pregnant, or who wish to have a baby. Patients with the following serious complications: 1.Cardiovascular abnormalities such as heart failure, angina pectoris, or arrhythmia that are difficult to control even after treatment. 2. Myocardial infarction within 6 months of onset 3. Renal failure 4. Active infectious disease except for viral hepatitis 5. Active gastrointestinal bleeding 6. Other active cancer requiring treatment 7. Hepatic encephalopathy or severe mental disorder 8. Severe drug allergy 9. Serious autoimmune disease. Other conditions that the physician deems inappropriate for the safe conduct of this study.
研究者
相似试验
已完成
不适用
Study on efficacy and safety of combination treatment with febuxostat and inosine for patients with heart failureheart failureJPRN-UMIN000025427Tsukuba International Clinical Pharmacology Clinic6
进行中（未招募）
1 期
Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients.EUCTR2018-003300-39-ESFundación para la Investigación Biomédica de Córdoba150
招募中
不适用
A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000009107Iwate Medical University60
已完成
不适用
Study of the clinical utility and safety in combination use of the GLI-1 analogue and Insulin degludec in type 2 diabetic patients.JPRN-UMIN000016966Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine30
已完成
不适用
Study of the clinical utility and safety in combination use of the GLP-1 analogue and BG in type 2 diabetic patientstype 2 diabetesJPRN-UMIN000009636Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine60